Similar articles

• [Lipid metabolism disorders in patients with retinal artery occlusions].

  Fellinger C, Schmut O, Hofmann H. Fellinger C, et al. Klin Monbl Augenheilkd. 1984 Feb;184(2):109-11. doi: 10.1055/s-2008-1054421. Klin Monbl Augenheilkd. 1984. PMID: 6716886 German.
• Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.

  Gilbert HS, Ginsberg H, Fagerstrom R, Brown WV. Gilbert HS, et al. Am J Med. 1981 Oct;71(4):595-602. doi: 10.1016/0002-9343(81)90212-6. Am J Med. 1981. PMID: 7282748
• [Determination of plasma levels of apolipoprotein E and of HDL-cholesterol in gouty patients].

  Frati E, Castagna ML, Bacarelli M, Giordano N, Fioravanti A, Pucci G, Marcolongo R. Frati E, et al. Boll Soc Ital Biol Sper. 1984 May 30;60(5):1063-9. Boll Soc Ital Biol Sper. 1984. PMID: 6590073 Italian.
• ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

  Winder AF, Richmond W, Vallance DT. Winder AF, et al. J Clin Pathol. 1997 Sep;50(9):721-34. doi: 10.1136/jcp.50.9.721. J Clin Pathol. 1997. PMID: 9389972 Free PMC article. Review. No abstract available.
• Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders.

  Salazar A, Pintó X, Mañá J. Salazar A, et al. Eur J Clin Invest. 2001 Dec;31(12):1070-7. doi: 10.1046/j.1365-2362.2001.00913.x. Eur J Clin Invest. 2001. PMID: 11903494 Review.